arrow
A

Antonio Pezzutto

Charité–Universitätsmedizin Berlin
H指数:41
被引数:6,806

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CD22 Specific T-Cell Receptor Enables Effective Adoptive T-Cell Therapy for B-cell malignancies

CD22特异性T细胞受体使B细胞恶性肿瘤的过继性T细胞疗法成为可能。

Blood
IF23.1
2025-10-210
PRE
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
LEUKEMIA
IF13.4
2020-05-0763
PREAI
Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study
LEUKEMIA
IF13.4
2020-02-1132
OAAI
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Brentuximab vedotin联合化疗治疗CD30-positive外周T细胞淋巴瘤 (ECHELON-2): 一项全球性、双盲、随机、3期临床试验

LANCET
IF88.5
2019-01-01535
OAAI